Literature DB >> 31032759

Lack of false-positive results for Clostridioides difficile toxins A and B using two commercial enzyme immunoassays in pediatric patients.

Aakash B Balaji1, Joseph S Sichel1, Larry K Kociolek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31032759      PMCID： PMC6915302          DOI： 10.1017/ice.2019.104

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  10 in total

1.  Clostridium difficile-Diagnostic and Clinical Challenges.

Authors:  Carey-Ann D Burnham; Erik R Dubberke; Larry K Kociolek; Christopher R Polage; Thomas V Riley
Journal:  Clin Chem       Date:  2015-12-11       Impact factor: 8.327

2.  National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations.

Authors:  Larry K Kociolek; Thomas J Sandora
Journal:  Am J Infect Control       Date:  2013-06-19       Impact factor: 2.918

3.  Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.

Authors:  Larry K Kociolek; Preeta K Kutty; Philip M Polgreen; Susan E Beekmann
Journal:  Infect Control Hosp Epidemiol       Date:  2019-02-15       Impact factor: 3.254

4.  Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study.

Authors:  Larry K Kociolek; Sameer J Patel; Stanford T Shulman; Dale N Gerding
Journal:  Infect Control Hosp Epidemiol       Date:  2015-04       Impact factor: 3.254

5.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

Review 6.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.

Authors:  Philip Toltzis; Michelle M Nerandzic; Elie Saade; Mary Ann O'Riordan; Sarah Smathers; Theoklis Zaoutis; Jason Kim; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2011-12-20       Impact factor: 3.254

8.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

9.  SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Clostridioides difficile prevention.

Authors:  Thomas J Sandora; Kristina K Bryant; Joseph B Cantey; Alexis M Elward; Deborah S Yokoe; Allison H Bartlett
Journal:  Infect Control Hosp Epidemiol       Date:  2018-08-30       Impact factor: 3.254

10.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.

Authors:  Timothy D Planche; Kerrie A Davies; Pietro G Coen; John M Finney; Irene M Monahan; Kirsti A Morris; Lily O'Connor; Sarah J Oakley; Cassie F Pope; Mike W Wren; Nandini P Shetty; Derrick W Crook; Mark H Wilcox
Journal:  Lancet Infect Dis       Date:  2013-09-03       Impact factor: 25.071
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.